ForMune is a medical-based company developing therapeutic vaccines and molecules for subsequent license.
ForMune develops therapeutic vaccines based on protein Extra Domain A of fibronectin. ForMune develops molecules for subsequent license to pharmaceutical and marketing companies
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 19, 2012 | Series Unknown | €4.40M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Fundación Caja Navarra | — | Series Unknown |